<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Journal of Clinical and Basic Research</title>
<title_fa>Journal of Clinical and Basic Research</title_fa>
<short_title>jcbr</short_title>
<subject>Medical Sciences</subject>
<web_url>http://jcbr.goums.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2538-3736</journal_id_issn>
<journal_id_issn_online>2538-3736</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.66224/jcbr</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1400</year>
	<month>1</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2021</year>
	<month>4</month>
	<day>1</day>
</pubdate>
<volume>5</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Comparison of Co-trimoxazole and Cephalexin Efficacy in Preventing Urinary 
Tract Infection among Children</title>
	<subject_fa>علوم پایه پزشکی</subject_fa>
	<subject>Basic medical sciences</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;strong&gt;Background and objectives: &lt;/strong&gt;Diagnosis and treatment of urinary tract infection (UTI) in children before kidney damage is necessary. The purpose of this study was to compare efficacy of co-trimoxazole and cephalexin in the prevention of recurrent UTI in children.&lt;br&gt;
&lt;strong&gt;Methods:&lt;/strong&gt; The study was performed on 100 children aged three months to 14 years who were referred to the Taleghani Pediatric Hospital in Gorgan (Iran) during 2016. The subjects had a history of UTI and required antibiotic prophylaxis to prevent UTI. They were divided into two groups of co-trimoxazole and cephalexin. Data were analyzed using SPSS (version 18) and at significance level of 0.05.&lt;br&gt;
&lt;strong&gt;Results:&lt;/strong&gt; Recurrent UTI was observed in eight children (16.0%) taking cephalexin and in six children (12.0%) receiving co-trimoxazole (p=0.56). Urine culture examination revealed Escherichia coli as the causative agent of UTI in six cases (75 %) receiving cephalexin and in five cases (83.3%) receiving co-trimoxazole (p=0.70). It should be noted that unilateral moderate hydronephrosis was the most frequent anomaly (n=26) in the study groups.&lt;br&gt;
&lt;strong&gt;Conclusion: &lt;/strong&gt;According to the results of the present study, both cephalexin and co-trimoxazole have similar efficacy in the prevention of UTI among children.&lt;br&gt;
&amp;nbsp;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Urinary tract infection, Children, Recurrent infection, Co-trimoxazole, Cephalexin</keyword>
	<start_page>17</start_page>
	<end_page>25</end_page>
	<web_url>http://jcbr.goums.ac.ir/browse.php?a_code=A-10-207-4&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Jabar</first_name>
	<middle_name></middle_name>
	<last_name> Parhiz</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846003164</code>
	<orcid>10031947532846003164</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Neonatal and Children&#039;s Health Research Center, Golestan University of Medical Sciences, Gorgan, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Sara </first_name>
	<middle_name></middle_name>
	<last_name>Rahafard</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846003165</code>
	<orcid>10031947532846003165</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Neonatal and Children&#039;s Health Research Center, Golestan University of Medical Sciences, Gorgan, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Samaneh </first_name>
	<middle_name></middle_name>
	<last_name>Sharifi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846003166</code>
	<orcid>10031947532846003166</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Neonatal and Children&#039;s Health Research Center, Golestan University of Medical Sciences, Gorgan, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Farshid </first_name>
	<middle_name></middle_name>
	<last_name>Kompani</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846003167</code>
	<orcid>10031947532846003167</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Neonatal and Children&#039;s Health Research Center, Golestan University of Medical Sciences, Gorgan, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
